Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Mol Biol (Noisy-le-grand) ; 67(5): 138-143, 2022 Feb 04.
Article in English | MEDLINE | ID: mdl-35818260

ABSTRACT

Reinfection rate with SARS-CoV-2 and degree of protection by the induced antibody after the first episode of the infection is not well known, so it makes a big dilemma for health care personnel (HCP) who work in the front line of combating SARS-CoV-2. In this study, we investigated the frequency of SARS-CoV-2 redetection among HCP after the initial onset of the infection in a children's hospital during one year. Out of 131 seropositive HCP, 13.7% of them were symptomatic and PCR positive during 74-360 days after first sampling. Analysis of demographic data of seropositive HCP showed a correlation between a higher number of family members, higher body mass index, and the existence of underlying diseases with SARS-CoV-2 redetection. In conclusion, reinfection is one of the important problems in the SARS-CoV-2 pandemic. Research on this topic can help us to find answers to questions for estimating the duration of human protection with produced immunity after the infection or vaccination.


Subject(s)
COVID-19 , SARS-CoV-2 , Antibodies, Viral , COVID-19/epidemiology , Child , Delivery of Health Care , Humans , Pandemics/prevention & control , Polymerase Chain Reaction , Reinfection
2.
Biomed Res Int ; 2021: 4923852, 2021.
Article in English | MEDLINE | ID: mdl-33816612

ABSTRACT

BACKGROUND: Haemophilus influenzae (H. influenzae) strains, which commonly reside as commensals within the human pharynx and can remain as an asymptomatic carrier, but become invasive leading to pneumonia, septic arthritis, or meningitis. The Pentavac (pentavalent vaccine, manufactured by India, SII (DTwP-HepB-Hib)) was introduced to the Iranian National Immunization Plan in November 2014. The aim of this study is to investigate H. influenzae type b (Hib) carrier rate among children under 6 years old in Tehran. METHODS: This cross-sectional study was performed on 902 children including vaccinated/unvaccinated in the age of 6 months to 6 years, in Tehran. Sampling was performed from July 2019 to September 2019. Nasopharyngeal samples were taken from children by sterile swab. The PCR method was used to extract DNA. Then, all H. influenzae isolates were initially confirmed by molecular tests. BexA was used to distinguish typeable H. influenzae strains from nontypeable Haemophilus influenzae (NTHi). RESULTS: A total of 902 children were enrolled in the study: 452 were female (51%). H. influenzae carriage rate was 267 (29%), of that 150 samples (16.6%) were typeable. The nasopharyngeal Hib carrier rate in the children was 2.6% (24/902). 262 cases did not receive Hib vaccine. Analysis in nonnursery's children aged 4 to 6 (unvaccinated) years showed that the lower educational level of father, mother, and family number correlated with increased odds of colonization of children with Hib. CONCLUSION: Our findings showed a significant decrease (60%) in the overall Hib nasopharyngeal carriage in healthy children under six years after 5 years after the start of Hib vaccination.


Subject(s)
Carrier State , Diphtheria-Tetanus-Pertussis Vaccine/administration & dosage , Haemophilus Infections , Haemophilus Vaccines/administration & dosage , Haemophilus influenzae type b/immunology , Nasopharynx , Poliovirus Vaccine, Inactivated/administration & dosage , Vaccination , Carrier State/immunology , Carrier State/microbiology , Carrier State/pathology , Carrier State/prevention & control , Child , Child, Preschool , Cross-Sectional Studies , Diphtheria-Tetanus-Pertussis Vaccine/immunology , Female , Haemophilus Infections/immunology , Haemophilus Infections/pathology , Haemophilus Infections/prevention & control , Haemophilus Vaccines/immunology , Humans , Infant , Iran , Male , Nasopharynx/immunology , Nasopharynx/microbiology , Poliovirus Vaccine, Inactivated/immunology , Vaccines, Combined/administration & dosage , Vaccines, Combined/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...